{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:12:10Z","timestamp":1769595130016,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11940-007-0014-5","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T07:44:22Z","timestamp":1214207062000},"page":"283-293","source":"Crossref","is-referenced-by-count":31,"title":["Leptomeningeal neoplasms"],"prefix":"10.1007","volume":"9","author":[{"given":"Jan","family":"Drappatz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy T.","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,24]]},"reference":[{"key":"14_CR1","first-page":"579","volume":"19","author":"J.B. Posner","year":"1978","unstructured":"Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579\u2013592.","journal-title":"Adv Neurol"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.1974.00490320010002","volume":"30","author":"M.E. Olson","year":"1974","unstructured":"Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 1974, 30:122\u2013137.","journal-title":"Arch Neurol"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"W.R. Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759\u2013772.","journal-title":"Cancer"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","volume":"223","author":"U. Herrlinger","year":"2004","unstructured":"Herrlinger U, Forschler H, Kuker W, et al.: Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 2004, 223:167\u2013178.","journal-title":"J Neurol Sci"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/0-387-24199-X_5","volume":"125","author":"H.H. Engelhard","year":"2005","unstructured":"Engelhard HH, Corsten LA: Leptomeningeal metastasis of primary central nervous system (CNS) neoplasms. Cancer Treat Res 2005, 125:71\u201385.","journal-title":"Cancer Treat Res"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"C.S. Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW, Vecht CJ: The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999, 246:810\u2013814.","journal-title":"J Neurol"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0009-9260(99)91181-9","volume":"54","author":"D.A. Collie","year":"1999","unstructured":"Collie DA, Brush JP, Lammie GA, et al.: Imaging features of leptomeningeal metastases. Clin Radiol 1999, 54:765\u2013771.","journal-title":"Clin Radiol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"R.J. Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995, 38:51\u201357.","journal-title":"Ann Neurol"},{"key":"14_CR9","first-page":"590","volume":"34","author":"T.M. Cheng","year":"1994","unstructured":"Cheng TM, O\u2019Neill BP, Scheithauer BW, Piepgras DG: Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurgery 1994, 34:590\u2013595; discussion 596.","journal-title":"Neurosurgery"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00019052-200012000-00005","volume":"13","author":"M.C. Chamberlain","year":"2000","unstructured":"Chamberlain MC: Neoplastic meningitis: a guide to diagnosis and treatment. Curr Opin Neurol 2000, 13:641\u2013648.","journal-title":"Curr Opin Neurol"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005956925637","volume":"38","author":"L.M. DeAngelis","year":"1998","unstructured":"DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998, 38:245\u2013252.","journal-title":"J Neurooncol"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(19950615)75:12<2919::AID-CNCR2820751220>3.0.CO;2-9","volume":"75","author":"M.J. Glantz","year":"1995","unstructured":"Glantz MJ, Hall WA, Cole BF, et al.: Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995, 75:2919\u20132931.","journal-title":"Cancer"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"R.N. Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 1987, 5:1655\u20131662.","journal-title":"J Clin Oncol"},{"issue":"Suppl5","key":"14_CR14","first-page":"78","volume":"13","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, Kim L, Choy H, Akerley W: Concurrent chemotherapy and radiotherapy in patients with brain tumors. Oncology (Williston Park) 1999, 13(Suppl 5):78\u201382.","journal-title":"Oncology (Williston Park)"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"M.J. Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110\u20133116.","journal-title":"J Clin Oncol"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005999228846","volume":"38","author":"T. Siegal","year":"1998","unstructured":"Siegal T: Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy? J Neurooncol 1998, 38:151\u2013157.","journal-title":"J Neurooncol"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","volume":"67","author":"W. Boogerd","year":"1991","unstructured":"Boogerd W, Hart AA, van der Sande JJ, Engelsman E: Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer 1991, 67:1685\u20131695.","journal-title":"Cancer"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","volume":"77","author":"K. Fizazi","year":"1996","unstructured":"Fizazi K, Asselain B, Vincent-Salomon A, et al.: Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 1996, 77:1315\u20131323.","journal-title":"Cancer"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-005-9044-6","volume":"78","author":"A.B. Lassman","year":"2006","unstructured":"Lassman AB, Abrey LE, Shah GD, et al.: Systemic high-dose intravenous methotrexate for central nervous system metastases. J Neurooncol 2006, 78:255\u2013260.","journal-title":"J Neurooncol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","volume":"16","author":"M.J. Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Recht L, et al.: High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 1998, 16:1561\u20131567.","journal-title":"J Clin Oncol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"M.J. Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA, et al.: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 54:1886\u20131893.","journal-title":"Neurology"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"S.A. Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, et al.: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 1993, 11:561\u2013569.","journal-title":"J Clin Oncol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1200\/JCO.1999.17.6.1825","volume":"17","author":"A. Gajjar","year":"1999","unstructured":"Gajjar A, Fouladi M, Walter AW, et al.: Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol 1999, 17:1825\u20131828.","journal-title":"J Clin Oncol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","volume":"41","author":"M.C. Chamberlain","year":"1991","unstructured":"Chamberlain MC, Corey-Bloom J: Leptomeningeal metastases: 111indium-DTPA CSF flow studies. Neurology 1991, 41:1765\u20131769.","journal-title":"Neurology"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","volume":"50","author":"W.P. Mason","year":"1998","unstructured":"Mason WP, Yeh SD, DeAngelis LM: 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1998, 50:438\u2013444.","journal-title":"Neurology"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/WNL.46.6.1674","volume":"46","author":"M.C. Chamberlain","year":"1996","unstructured":"Chamberlain MC, Kormanik PA: Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 1996, 46:1674\u20131677.","journal-title":"Neurology"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1005982826121","volume":"38","author":"M.C. Chamberlain","year":"1998","unstructured":"Chamberlain MC: Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 1998, 38:135\u2013140.","journal-title":"J Neurooncol"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/0-387-24199-X_9","volume":"125","author":"M. Mehta","year":"2005","unstructured":"Mehta M, Bradley K: Radiation therapy for leptomeningeal cancer. Cancer Treat Res 2005, 125:147\u2013158.","journal-title":"Cancer Treat Res"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1005995127938","volume":"38","author":"P.E. Hanssens","year":"1998","unstructured":"Hanssens PE, Lagerwaard FJ, Levendag PC: Principles of radiotherapy of neoplastic meningosis. J Neurooncol 1998, 38:145\u2013150.","journal-title":"J Neurooncol"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2407-7-18","volume":"7","author":"R. Addeo","year":"2007","unstructured":"Addeo R, Caraglia M, Faiola V, et al.: Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer 2007, 7:18.","journal-title":"BMC Cancer"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijrobp.2004.04.061","volume":"61","author":"E. Verger","year":"2005","unstructured":"Verger E, Gil M, Yaya R, et al.: Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 2005, 61:185\u2013191.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","volume":"64","author":"A.M. Omuro","year":"2005","unstructured":"Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM: Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 2005, 64:1625\u20131627.","journal-title":"Neurology"},{"key":"14_CR33","first-page":"49","volume":"47","author":"D.I. Sandberg","year":"2000","unstructured":"Sandberg DI, Bilsky MH, Souweidane MM, et al.: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 2000, 47:49\u201354; discussion 54\u201355.","journal-title":"Neurosurgery"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1200\/JCO.2005.06.053","volume":"23","author":"S.M. Blaney","year":"2005","unstructured":"Blaney SM, Balis FM, Berg S, et al.: Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol 2005, 23:1555\u20131563.","journal-title":"J Clin Oncol"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2146\/ajhp060165","volume":"63","author":"D.C. Gammon","year":"2006","unstructured":"Gammon DC, Bhatt MS, Tran L, et al.: Intrathecal topotecan in adult patients with neoplastic meningitis. Am J Health Syst Pharm 2006, 63:2083\u20132086.","journal-title":"Am J Health Syst Pharm"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1992.10.1.143","volume":"10","author":"S.L. Berg","year":"1992","unstructured":"Berg SL, Balis FM, Zimm S, et al.: Phase I\/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 1992, 10:143\u2013148.","journal-title":"J Clin Oncol"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/1078-0432.CCR-05-2094","volume":"12","author":"S. Gururangan","year":"2006","unstructured":"Gururangan S, Petros WP, Poussaint TY, et al.: Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res 2006, 12:1540\u20131546.","journal-title":"Clin Cancer Res"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","volume":"25","author":"J.L. Rubenstein","year":"2007","unstructured":"Rubenstein JL, Fridlyand J, Abrey L, et al.: Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 2007, 25:1350\u20131356.","journal-title":"J Clin Oncol"},{"key":"14_CR39","first-page":"1373","volume":"15","author":"H.J. Stemmler","year":"2006","unstructured":"Stemmler HJ, Schmitt M, Harbeck N, et al.: Application of intrathecal trastuzumab (Herceptin trade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Oncol Rep 2006, 15:1373\u20131377.","journal-title":"Oncol Rep"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1526-8209(11)70419-0","volume":"2","author":"L.R. Laufman","year":"2001","unstructured":"Laufman LR, Forsthoefel KF: Use of intrathecal trastuzumab in a patient with carcinomatous meningitis. Clin Breast Cancer 2001, 2:235.","journal-title":"Clin Breast Cancer"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1470-2045(06)70864-6","volume":"7","author":"C. Platini","year":"2006","unstructured":"Platini C, Long J, Walter S: Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab. Lancet Oncol 2006, 7:778\u2013780.","journal-title":"Lancet Oncol"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1096-911X(20001201)35:6<716::AID-MPO51>3.0.CO;2-0","volume":"35","author":"K. Kramer","year":"2000","unstructured":"Kramer K, Cheung NK, Humm JL, et al.: Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8. Med Pediatr Oncol 2000, 35:716\u2013718.","journal-title":"Med Pediatr Oncol"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1005948722912","volume":"38","author":"U. Herrlinger","year":"1998","unstructured":"Herrlinger U, Weller M, Schabet M: New aspects of immunotherapy of leptomeningeal metastasis. J Neurooncol 1998, 38:233\u2013239.","journal-title":"J Neurooncol"},{"key":"14_CR44","first-page":"47","volume":"11","author":"J. Drappatz","year":"2005","unstructured":"Drappatz J, Batchelor T: Leptomeningeal and peripheral nerve metastases. Continuum 2005, 11:47\u201368.","journal-title":"Continuum"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/0-387-24199-X_8","volume":"125","author":"S.L. Berg","year":"2005","unstructured":"Berg SL, Chamberlain MC: Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management. Cancer Treat Res 2005, 125:121\u2013146.","journal-title":"Cancer Treat Res"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M. Balm","year":"1996","unstructured":"Balm M, Hammack J: Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996, 53:626\u2013632.","journal-title":"Arch Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-007-0014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-007-0014-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-007-0014-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:51Z","timestamp":1559422611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-007-0014-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11940-007-0014-5","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}